Naomi Hunder

Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1

Naomi Hunder, Herschel Wallen, Jianhong Cao et al. · New England Journal of Medicine · 2008 · 894 citations · Full text

Cell Therapy, Immunology, Melanoma-associated Antigen Ny-eso-1 +16

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Craig H. Moskowitz, Auayporn Nademanee, Tamás Masszi et al. · The Lancet · 2015 · 726 citations · Full text

Lymphoid Neoplasia, Cell Therapy, Transplantation +10

Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study

Anas Younes, Joseph M. Connors, Steven I. Park et al. · The Lancet Oncology · 2013 · 269 citations

Dose-escalation Study, Lymphoid Neoplasia, Medicine +8

Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection†

Andrew J. Muir, Mitchell L. Shiffman, Atif Zaman et al. · Hepatology · 2010 · 246 citations · Full text

Hla–drb1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis

Cornelia M. Weyand, Naomi Hunder, Kevin C. Hicok et al. · Arthritis & Rheumatism · 1994 · 191 citations